BDL
ABBV icon

Bey-Douglas LLC’s AbbVie ABBV Stock Holding History

Bey-Douglas LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$424K Sell
1,948
-154
-7% -$34.2K 0.37% 31
2025
Q4 		$480K Buy
2,102
+92
+5% +$21K 0.38% 26
2025
Q3 		$465K Sell
2,010
-69
-3% -$14.1K 0.35% 32
2025
Q2 		$386K Buy
2,079
+453
+28% +$84.2K 0.23% 31
2025
Q1 		$341K Sell
1,626
-72
-4% -$14K 0.31% 28
2024
Q4 		$302K Sell
1,698
-26
-2% -$4.78K 0.26% 28
2024
Q3 		$341K Sell
1,724
-1
-0.1% -$187 0.3% 27
2024
Q2 		$291K Buy
1,725
+50
+3% +$8.28K 0.27% 30
2024
Q1 		$305K Buy
1,675
+46
+3% +$7.93K 0.29% 30
2023
Q4 		$252K Buy
+1,629
New +$237K 0.26% 32

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bey-Douglas LLC's ABBV Position: Q1 2026 in Review

Bey-Douglas LLC reduced its AbbVie (ABBV) stake by 7.3% in Q1 2026, selling an estimated $34.2K and leaving 1,948 shares worth $424K. The position accounts for 0.37% of the portfolio, ranked #31.

Bey-Douglas LLC first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $480K in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Bey-Douglas LLC held 1,948 shares of AbbVie worth $424K as of Q1 2026.
  • Bey-Douglas LLC sold 154 AbbVie shares in Q1 2026, an estimated $34.2K.
  • AbbVie made up 0.37% of Bey-Douglas LLC's portfolio in Q1 2026, its #31 holding.
  • Bey-Douglas LLC first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • Bey-Douglas LLC's AbbVie position peaked at $480K in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bey-Douglas LLC's 13F filing for Q1 2026, filed 12 May 2026.